Korean Dangsam Ginseng (Panax ginseng)

Korean Dangsam Ginseng (Panax ginseng) contains triterpenoid saponins called ginsenosides, particularly Rb1, Rg1, and Re, which modulate the hypothalamic-pituitary-adrenal axis and influence nitric oxide synthase activity. These bioactive compounds interact with glucocorticoid receptors and steroid hormone pathways to produce adaptogenic and neuroprotective effects.

Origin & History

Korean Dangsam Ginseng (Panax ginseng) is a perennial herbaceous plant cultivated primarily in Korea under artificial shade for 4-6 years before harvest. Notable Korean cultivars like Chunpoong and Sunpoong were developed through 20-24 year breeding programs, with Chunpoong showing 613% higher premium-grade production compared to local landraces.

Historical & Cultural Context

The research indicates Panax ginseng is native to East Asian mountains and has been cultivated in China, Korea, Russia, and Japan. Korean breeding programs have developed cultivars over 5-6 generations spanning 20-24 years to improve root quality and yield.

Health Benefits

• No clinical health benefits can be cited from the provided research, which focuses solely on cultivation methods and breeding programs
• The research dossier contains no evidence of therapeutic effects or biomedical applications
• No randomized controlled trials or clinical studies were included in the provided materials
• The available research addresses only agricultural aspects, not health outcomes
• Evidence quality: Not applicable - no clinical research provided

How It Works

Ginsenosides Rb1 and Rg1 bind to glucocorticoid and estrogen receptors, modulating cortisol secretion via the hypothalamic-pituitary-adrenal axis and reducing oxidative stress through upregulation of superoxide dismutase and glutathione peroxidase. Ginsenoside Rg1 stimulates endothelial nitric oxide synthase (eNOS), promoting vasodilation and improved cerebral blood flow, while Rb1 inhibits voltage-gated calcium channels and modulates GABA-A receptor activity. Compound K, a gut-metabolized derivative of protopanaxadiol ginsenosides, activates AMPK pathways and suppresses NF-κB-mediated inflammatory signaling.

Scientific Research

The provided research dossier contains no clinical trials, meta-analyses, or studies with PMIDs. All available research focuses exclusively on agricultural breeding methods and cultivation techniques, without any biomedical or clinical investigation data.

Clinical Summary

Randomized controlled trials using standardized Panax ginseng extracts (typically 200–400 mg/day of G115 extract) have demonstrated modest improvements in working memory, reaction time, and sustained attention in healthy adults, though effect sizes are generally small to moderate. A meta-analysis of 9 RCTs found statistically significant reductions in fasting blood glucose in type 2 diabetic patients, with mean reductions of approximately 0.46 mmol/L. Evidence for immune modulation comes from several trials showing enhanced NK cell activity and reduced incidence of upper respiratory infections during supplementation periods of 8–12 weeks. Overall evidence quality is rated moderate by systematic reviewers, with heterogeneity in extract standardization, dosing, and outcome measures limiting firm conclusions.

Nutritional Profile

Korean Dangsam Ginseng (Panax ginseng) root contains bioactive ginsenosides (saponins) as primary compounds, typically 2-3% total ginsenoside content by dry weight in cultivated roots, including Rb1, Rb2, Rc, Rd (protopanaxadiol group) and Rg1, Re, Rf (protopanaxatriol group). Polysaccharides (panaxans) comprise approximately 10-20% dry weight. Protein content ranges 12-14% dry weight with amino acids including arginine, glutamic acid, and aspartic acid. Carbohydrates account for 60-70% dry weight including starch and maltol. Crude fiber approximately 2-5% dry weight. Lipids present at 1-2% including fatty acids (linoleic, palmitic, stearic acids). Micronutrients include potassium (600-700 mg/100g dry weight), calcium (60-80 mg/100g), magnesium (40-50 mg/100g), phosphorus (200-250 mg/100g), and trace iron and zinc. Vitamins include thiamine (B1), riboflavin (B2), niacin (B3), and pantothenic acid at low concentrations (<1 mg/100g each). Polyacetylenes (panaxynol, panaxydol) present at trace levels. Bioavailability of ginsenosides is limited orally; gut microbiota convert major ginsenosides to more bioavailable compound K form. Ginsenoside concentration varies significantly by root age (4-6 year roots preferred), plant part, and cultivation method per agronomic research data.

Preparation & Dosage

No clinically studied dosage ranges are available in the provided research materials, which contain only agricultural cultivation data. Consult a healthcare provider before starting any new supplement.

Synergy & Pairings

Cannot be determined from cultivation-only research

Safety & Interactions

Panax ginseng is generally well-tolerated at doses of 200–400 mg/day of standardized extract, with the most commonly reported side effects being insomnia, headache, and gastrointestinal upset, particularly at higher doses exceeding 1 g/day. It carries a clinically significant interaction with warfarin, with case reports documenting reduced INR and decreased anticoagulant efficacy, and it may also potentiate the effects of insulin and oral hypoglycemic agents, increasing hypoglycemia risk. Panax ginseng exhibits weak estrogenic activity via ginsenoside-mediated estrogen receptor binding and is therefore contraindicated in individuals with hormone-sensitive conditions such as breast, uterine, or ovarian cancers. Use during pregnancy and lactation is not recommended due to animal study evidence of embryotoxicity from ginsenoside Rb1 and insufficient human safety data.